GLP-1 receptor agonists — the drug class that includes Ozempic, Wegovy and Mounjaro — were linked to improved survival among colon cancer patients in a new observational study from UC San Diego.
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...
Trump announced new deals with Eli Lilly and Novo Nordisk to lower GLP-1 costs for Medicare, Medicaid, and cash-paying patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback